1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Donor Site Complication: new trials by email Literature Review of Donor Site Complication trials Research Report on Donor Site Complication
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2. Fibrosis-Inhibiting-Compound-FS2, Vehicle moisture balancing base - Scar, Cicatrix | Phase 2 | Unknown | University of British Columbia | 50 | 2019-12-05 | 2019-12-17 |
| TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds TWB-103 Group, Placebo Group - Donor Site Complication | Phase 1 / Phase 2 | Completed | Transwell Biotech Co., Ltd. | 48 | 2017-07-06 | 2023-07-28 |
Cicatrix (1) · Cicatrix, Hypertrophic (1) · Keloid (1)
Collagen Diseases (1) · Connective Tissue Diseases (1) · Fibrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin and Connective Tissue Diseases (1)
Transwell Biotech Co., Ltd. (1) · University of British Columbia (1)
Canada (1) · Japan (1) · Taiwan (1)